Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 616 results found. Search for [ coronavirus vaccine developed in India ]

Results 180 to 200 of 616
PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


Joe C Mathew
November 24, 2020
In an open letter to Prime Minister Narendra Modi on November 24, the civil society representatives said the current incidence, prevalence, and fatality status of COVID-19 disease in India, do not call for such an approach


Joe C Mathew
November 24, 2020
The announcement that comes a day after Oxford-Astrazeneca announced a similar level of efficacy for its COVID-19 vaccine allows India to hope for two vaccines to fight the COVID-19 pandemic in the country


BusinessToday.In
November 24, 2020
The researchers said they could not explicate why the half dose manifested better protection, but added it may be that it prompts the immune system differently


BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


BusinessToday.In
November 24, 2020
Serum Institute has tied up with British-Swedish pharmaceutical firm AstraZeneca and the University of Oxford to mass-produce the Covishield vaccine to fight back COVID-19 virus


BusinessToday.In
November 23, 2020
Tarun Gogoi was undergoing treatment for post-Covid complications at the Gauhati Medical College Hospital, Assam Health Minister Himanta Biswas Sharma confirmed


BusinessToday.In
November 23, 2020
It has been found that one of the vaccine's dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply, says AstraZeneca


BusinessToday.In
November 23, 2020
The panel-led by Dravida Munnetra Kazhagam (DMK) lawmaker Kanimozhi Karunanidhi will hear officials of pharmaceutical departments on the status of the COVID-19 vaccine


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


BusinessToday.In
November 23, 2020
The Prime Minister is expected to hold two back-to-back meetings, one with those states with high caseloads and another related to vaccine distribution strategy.


BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh


BusinessToday.In
November 21, 2020
The participant was admitted to a hospital with viral pneumonitis, few days after being given the vaccine. He was discharged after a week.


Joe C Mathew
November 21, 2020
\"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option),\" says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-19


BusinessToday.In
November 21, 2020
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this week


BusinessToday.In
November 21, 2020
Pfizer's CEO Albert Bourla confirmed the company's application and said in a video statement,  'It is with great pride and joy - and even a little relief - that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA's hands.'


BusinessToday.In
New Delhi, November 19, 2020
A fast and cheap coronavirus testing kit that can provide results in 40 minutes was launched in Delhi on Thursday. The indigenously developed testing kit for coronavirus based on the gene-editing technology CRISPR called Feluda was launched by Tata group in collaboration with the Apollo group of hospitals. The test is likely to be cheaper than the current gold standard RT-PCR and equally accurate, helping in scaling up COVID-19 testing. Watch the video for more.Also Read: Pfizer share rises nearly 7% after firm says COVID-19 vaccine 95% effective


BusinessToday.In
November 19, 2020
Union Health Minister Harsh Wardhan asserted that India has managed despite facing scarcities of PPE kits, ventilators and N-95 masks at the start of the pandemic and is now leading the research on the vaccine globally


BusinessToday.In
November 19, 2020
Late-stage trials of the Oxford vaccine are still awaited but hopes are high that it'll also join frontrunners' league with Pfizer, Moderna and Russia's Sputnik V


BusinessToday.In
November 18, 2020
Narayana Murthy appealed to companies who can afford to bear the cost to give the vaccines for free. He also said that UN Security Council members should share a major part of this cos


PAGES 10 OF 31  678910